Cleared Traditional

K124038 - BEDSIDE PAEDIATRIC EARLY WARNING SYSTEM (BEDSIDEPEWS)

K124038 is an FDA 510(k) clearance for BEDSIDE PAEDIATRIC EARLY WARNING SYSTEM..., manufactured by Bedside Clinical Systems, Inc.. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 175-day FDA review.

K124038 · Bedside Clinical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2013
Decision
175d
Days
Class 2
Risk

K124038 is an FDA 510(k) clearance for the BEDSIDE PAEDIATRIC EARLY WARNING SYSTEM (BEDSIDEPEWS). Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Bedside Clinical Systems, Inc. (Austin, US). The FDA issued a Cleared decision on June 21, 2013 after a review of 175 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bedside Clinical Systems, Inc. devices

FDA 510(k) Submission Details - K124038

510(k) Number K124038 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 28, 2012
Decision Date June 21, 2013
Days to Decision 175 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
50d slower than avg
Panel avg: 125d · This submission: 175d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 175
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K124038.
VITAL SIGNS MONITOR, CONNEX VITAL SIGNS MONITOR
K132808 · Welch Allyn, Inc. · Nov 2013
MRI PATIENT MONITORING SYSTEM
K132359 · Invivo Corporation · Aug 2013
EXPRESSION MR200 MRI PATIENT MONITORING SYSTEM, EXPRESSION IP5 INFORMATION PORTAL
K131382 · Invivo Corporation · Jul 2013
740 SELECT
K130411 · Cas Medical Systems, Inc. · May 2013
VITAL SYNC INFORMATICS MANAGER & VIRTUAL PATIENT MONITORING PLATFORM
K130796 · Covidien · May 2013
MRI PATIENT MONITORING SYSTEM (MODEL 865214)
K124061 · Invivo Corporation · Feb 2013